Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011, Article ID 921231, 5 pages
http://dx.doi.org/10.1155/2011/921231
Review Article

Target Therapies in Lung Cancer

Department of Medical Oncology, National Cancer Institute, Via Gallini 2, CRO-IRCCS, 33081 Aviano, Italy

Received 1 December 2010; Accepted 27 January 2011

Academic Editor: E. Felip

Copyright © 2011 A. Bearz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • M. Reck, “What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?,” Annals of Oncology, vol. 23, no. suppl8, pp. viii28–viii34, 2012. View at Publisher · View at Google Scholar
  • P. Trenta, A. Palazzo, F. Morano, E. Cortesi, M. L. Mancini, and A. Passaro, “Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer,” Current Medicinal Chemistry, vol. 19, no. 22, pp. 3689–3700, 2012. View at Publisher · View at Google Scholar
  • Gang Li, Jingfeng Zhao, Xianjing Peng, Jian Liang, Xin Deng, and Yuxiang Chen, “Radiation/Paclitaxel Treatment of p53-Abnormal Non-Small Cell Lung Cancer Xenograft Tumor and Associated Mechanism,” Cancer Biotherapy & Radiopharmaceuticals, vol. 27, no. 4, pp. 227–233, 2012. View at Publisher · View at Google Scholar
  • Friederike Göke, Joerg Ellinger, Ulrich Gerigk, Falko Fend, Patrick Wagner, Andreas Schroeck, Sven Perner, Alina Franzen, Roopika Menon, Diane Goltz, Robert Kirsten, Diana Boehm, Wenzel Vogel, Antonia Gok̈e, and Veit Scheble, “Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors,” Chest, vol. 142, no. 4, pp. 1020–1026, 2012. View at Publisher · View at Google Scholar
  • Friederike Göke, Maike Bode, Alina Franzen, Robert Kirsten, Diane Goltz, Antonia Göke, Rakesh Sharma, Diana Boehm, Wenzel Vogel, Patrick Wagner, Claudia Lengerke, Glen Kristiansen, Jutta Kirfel, Tobias Van Bremen, Friedrich Bootz, Lynn E Heasley, Andreas Schröck, and Sven Perner, “Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck,” Modern Pathology, 2013. View at Publisher · View at Google Scholar
  • Andreas Schröck, Friederike Göke, Patrick Wagner, Maike Bode, Alina Franzen, Sebastian Huss, Abbas Agaimy, Stephan Ihrler, Robert Kirsten, Glen Kristiansen, Friedrich Bootz, Claudia Lengerke, and Sven Perner, “Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer,” Head & Neck, 2014. View at Publisher · View at Google Scholar
  • Meng-Feng Tsai, Chi-Chung Wang, and Jeremy J.W. Chen, “Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer,” World Journal of Clinical Oncology, vol. 5, no. 5, pp. 865–873, 2014. View at Publisher · View at Google Scholar
  • Ya-Nian Zhang, Xiao-Yang Wu, Ning Zhong, Jun Deng, Lu Zhang, Wen Chen, Xing Li, and Chong-Jun Zhong, “Stimulatory effects of sorafenib on human non-small cell lung cancer cells in vitro by regulating MAPK/ERK activation,” Molecular Medicine Reports, vol. 9, no. 1, pp. 365–369, 2014. View at Publisher · View at Google Scholar
  • Mendes, Antunes, Abrantes, Gonçalves, Nobre-Gois, Sarmento, Botelho, and Rosa, “Lung cancer: The immune system and radiation,” British Journal of Biomedical Science, vol. 72, no. 2, pp. 78–84, 2016. View at Publisher · View at Google Scholar